Psychemedics Corp (PMD)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Raymond C. Kubacki
Employees:
250
125 NAGOG PARK, ACTON, MA 01720
978-206-8220

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. Its testing methods utilize a technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The company performs custom-designed enzyme immunoassay on the liquid supernatant, with confirmation testing by mass spectrometry. It provides screening and confirmation by mass spectrometry for cocaine; marijuana; phencyclidine; amphetamines including ecstasy; and opiates such as including heroin, hydrocodone, hydromorphone, oxycodone and codeine. Psychemedics was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.

Data derived from most recent annual or quarterly report
Market Cap 39.738 Million Shares Outstanding5.542 Million Avg 30-day Volume 20.586 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.13
Price to Revenue1.7571 Debt to Equity0.3092 EBITDA-2.125 Million
Price to Book Value2.6792 Operating Margin-29.2127 Enterprise Value36.097 Million
Current Ratio2.454 EPS Growth-5.714 Quick Ratio1.434
1 Yr BETA 0.7239 52-week High/Low 8.84 / 4.92 Profit Margin-18.5145
Operating Cash Flow Growth-215.7313 Altman Z-Score1.6188 Free Cash Flow to Firm -5.641 Million
View SEC Filings from PMD instead.

View recent insider trading info

Funds Holding PMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KUBACKI RAYMOND C JR CHAIRMAN, CEO & PRESIDENT

  • Officer
  • Director
234,312 2021-11-12 2

SCHAFFER MICHAEL I VP OF LABORATORY OPERATIONS

  • Officer
32,883 2021-11-12 2

DOUCOT CHARLES M EXECUTIVE VICE PRESIDENT

  • Officer
28,925 2021-11-12 2

WEINERT FRED J

  • Director
58,583 2021-05-13 1

TOMENSON WALTER S

  • Director
62,399 2021-05-13 1

CONNICK HARRY F SR

  • Director
90,112 2021-05-13 1

DAVIS ROBYN C

  • Director
13,000 2021-05-13 3

LIMBEK ANDREW VICE PRESIDENT & CONTROLLER

  • Officer
7,500 2021-05-13 3

ALLEN A CLINTON

  • Director
3,000 2020-11-13 0

LERNER NEIL VP - FINANCE

  • Officer
25,866 2020-11-11 0

DYKE JAMES V. VICE PRESIDENT - SALES

  • Officer
19,781 2017-05-23 0

HUIZENGA H WAYNE

  • EXIT FILING
No longer subject to file 2010-12-21 0

COMPTON JONATHAN D VICE PRESIDENT - MARKETING

  • Officer
7,583 2010-05-15 0

THISTLE WILLIAM R SR. VP AND GEN. COUNSEL

  • Officer
17,001 2010-05-10 0

RUDDY RAYMOND J VICE PRESIDENT/CONTROLLER

  • Officer
2,921 2010-04-07 0

CHMIELESKI JENNIFER VICE PRESIDENT, CONTROLLER

  • Officer
1,200 2008-05-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PSYCHEMEDICS CORP PMD 2022-01-17 22:15:04 UTC -0.5222 0.5922 700000
PSYCHEMEDICS CORP PMD 2022-01-17 21:45:03 UTC -0.5222 0.5922 700000
PSYCHEMEDICS CORP PMD 2022-01-17 21:15:03 UTC -0.5222 0.5922 700000
PSYCHEMEDICS CORP PMD 2022-01-17 20:45:03 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 20:15:04 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 19:45:03 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 19:15:03 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 18:45:03 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 18:15:03 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 17:45:03 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 17:15:03 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 16:45:03 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 16:15:04 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 15:45:03 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 15:15:03 UTC -1.2075 1.2775 700000
PSYCHEMEDICS CORP PMD 2022-01-17 14:45:03 UTC -0.4816 0.5516 700000
PSYCHEMEDICS CORP PMD 2022-01-17 14:15:03 UTC -0.4816 0.5516 700000
PSYCHEMEDICS CORP PMD 2022-01-17 13:45:03 UTC -0.4816 0.5516 700000
PSYCHEMEDICS CORP PMD 2022-01-17 13:15:03 UTC -0.4816 0.5516 700000
PSYCHEMEDICS CORP PMD 2022-01-17 12:45:03 UTC -0.4816 0.5516 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments